Skip to main content

Month: April 2021

Active Biotech AB Interim report January – March 2021  

Financing completed and good progress in the projects First quarter in briefAgreement signed for manufacturing of a topical ophthalmic formulation and capsules of laquinimod for use in clinical studies Activities are ongoing according to plan in the naptumomab and tasquinimod projectsCorporateRights issue prospectus published on January 5, 2021 Rights issue oversubscribed by 175% and added 76.2 MSEK to liquidity before issue expensesEvents after the end of the periodActive Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical Trial of NaptumomabFinancial summary  SEK M Jan-Mar Full-year  2021    2020 2020           Net sales – 0,5 6,7  Operating loss/loss -9,7 -9,7 -32,3  Profit/loss after tax -9,8 -10,1 -32,2  Earnings per share (SEK) -0,05 -0,06 -0,19  Cash and cash equivalents...

Continue reading

Active Biotech AB Delårsrapport januari – mars 2021  

        Finansiering slutförd och goda framsteg i projekten Händelser under kvartal 1Avtal tecknat för tillverkning av kliniskt studiematerial av ögondroppsformulering och kapslar av laquinimod Aktiviteter pågår enligt plan för projekten naptumomab och tasquinimodFöretagetProspekt för nyemission offentliggjordes den 5 januari Företrädesemission övertecknad med 175 % och tillförde 72,6 MSEK före emissionskostnaderHändelser efter kvartal 1Active Biotech och NeoTX tillkännager IND-godkännande från FDA för klinisk fas II-studie med naptumomabEkonomisk översiktMSEK  jan-mar Helår  2021    2020 2020           Nettoomsättning – 0,5 6,7  Rörelseresultat -9,7 -9,7 -32,3  Resultat efter skatt -9,8 -10,1 -32,2  Resultat per aktie (SEK) -0,05 -0,06 -0,19  Likvida medel (vid periodens slut) 92,0 47,9 26,2  För...

Continue reading

NORTHBAZE GROUP AB (PUBL) OFFENTLIGGÖR ÅRSREDOVISNING FÖR RÄKENSKAPSÅRET 2020

Årsredovisningen och revisionsberättelsen för Northbaze Group koncernen samt moderbolaget för räkenskapsåret 2020 finns nu tillgängligt, antingen via bifogad PDF eller via vår hemsida: https://northbazegroup.com/. Detta inför årsstämman den 26 maj 2021. Göteborg den 21:a april 2021. För mer information, vänligen kontakta: Henrik Andersson, verkställande direktörMobil: +46 761 99 35 55E-mail: henrik.andersson@northbazegroup.com Om Northbaze Group ABNorthbaze Group grundades 2006 och har under åren utökat sin målbild till en affärsidé som är att utveckla och ta fram innovativa och funktionella produkter inom audio, IT- och mobiltillbehörsområdet för att förenkla och förbättra människors upplevelse av mobila enheter samt brygga samman människors liv med dagens teknik. Genom att vi kontrollerar tillverkningen och har ett nära samarbete med...

Continue reading

BW Energy: 2021 Annual General Meeting – Notice

2021 Annual General Meeting – Notice Notice is hereby given that the 2021 Annual General Meeting of BW Energy Limited will be held at Washington Mall Phase 2, 4th Floor, Suite 400, 22 Church Street, HM 1189, Hamilton HM EX, Bermuda, on 14 May 2021 at 5:00 p.m. (Bermuda time). Please see the attached documents in relation to the Annual General Meeting:Chairman’s Letter Notice of the 2021 AGM, together with Appendix I of the Notice – Dividend Policy Form of Proxy Recommendations from the Nomination CommitteeFor further information, please contact:Knut R. Sæthre, CFO, +47 91 11 78 76ir@bwenergy.no About BW Energy:BW Energy is a growth E&P company with a differentiated strategy targeting proven offshore oil and gas reservoirs through low risk phased developments. The Company has access to existing FPSOs to reduce time to first...

Continue reading

Northbaze Group investerar i ett nytt Utvecklings- & Innovationscenter för Adiantes

Affärsområdet Adiantes inom Smart Mobility och dess OEM- och Private Label-verksamhet inom premiumlädersegmentet har expanderat expansivt under 2019 och framåt. Som ett nästa steg fokuserar Adiantes på att ytterligare förbättra innovations- och utvecklingsmöjligheterna genom att etablera ett nytt och modernt Utvecklings- & Innovationscenter hos Adiantes huvudkontor i Bangkok. Denna förbättring gör det möjligt för Adiantes att tillhandahålla ytterligare funktioner till sina kunder och att samarbeta nära i design- och innovationsprocesser för de olika premiumvarumärkena. Projektet innefattar ett planerat samarbete med en av de ledande italienska mode- och designskolorna, med utbildning på plats hos oss och kunskapsöverföring samt samarbete från ledande kandidater från modedesign och mönstermakare med vår organisation. Northbaze Group’s...

Continue reading

Northbaze Group invest in a new Development- & Innovation Centre for Adiantes

The business area Adiantes within Smart Mobility and its OEM- and Private Label business within the premium leather segment has expanded rapidly over 2019 and forward. As a next step Adiantes is focusing in further enhancing innovation and development capabilities by establishing a new, modern Development- & Innovation Centre at Adiantes main office in Bangkok. This enhanced service will allow Adiantes to provide additional capabilities to their customers and to co-partner closely in design and innovation processes within the different premium brands. The project includes a planned collaboration with one of the leading Italian fashion and design schools, with on-site training and know how transfer provided by leading fashion design and pattern maker graduates. Northbaze Group investment in the project is a continuation of the value...

Continue reading

Ramsay Sante successfully refinanced its syndicated debt

Paris, Thursday April 22, 2021 Ramsay Santé successfully refinanced its syndicated debt On 22 April 2021, the Ramsay Santé Group refinanced its entire syndicated debt (TLB 1, 2 and 3), which was due in October 2022 and October 2024 and, for the first time, introduced social and environmental objectives to its debt. Ramsay Santé as borrower has entered into a €1,650m term and revolving senior facilities agreement with BNP Paribas as coordinator and arranger, Crédit Agricole CIB and Mediobanca as arrangers, comprising two TLB facilities of €700m and €750m respectively, a €100m Capex facility and a €100m RCF. This senior debt, which matures on April 22, 2026 for up to €900m and on April 22, 2027 for up to €750m, has enabled the Group to refinance in whole its existing senior debt and is otherwise intended to finance the general corporate...

Continue reading

RAMSAY SANTE refinance avec succès sa dette syndiquée

Communiqué de presse Ramsay Santé refinance avec succès sa dette syndiquée                                                                                               Paris, jeudi 22 avril 2021 – Le Groupe Ramsay Santé a procédé, le 22 avril 2021, au refinancement intégral de sa dette syndiquée (TLB 1, 2 et 3) dont les échéances étaient octobre 2022 et octobre 2024 et y attache, pour la première fois, des objectifs sociaux et environnementaux. Ramsay Santé en qualité d’emprunteur a conclu avec BNP Paribas en tant que coordinateur et arrangeur, Crédit Agricole CIB et Mediobanca en tant qu’arrangeurs, un contrat de crédits « dette senior » à terme et renouvelable d’un montant global de €1 650m comprenant deux tranches TLB de respectivement €700m et €750m, un crédit Capex de €100m et un RCF de €100m. Cette dette senior, remboursable...

Continue reading

Thermoplastic Elastomers Market to Hit USD 39,424.6 Million by 2027; Rising Technological Advancements to Spur Demand, Says Fortune Business Insights™

Pune, India, April 22, 2021 (GLOBE NEWSWIRE) — The global thermoplastic elastomers market is set to gain traction from the rising demand for bio-based products to increase sustainability and support environmental protection. Fortune Business Insights™ published this information in a new study, titled, “Thermoplastic Elastomer Market Size, Share & COVID-19 Impact Analysis, By Type (Styrenic Block Copolymers, Thermoplastic Polyurethane, Thermoplastic Vulcanizates, Thermoplastic Polyolefins, Copolyester Elastomers, and Others), By Application (Automotive, Building & Construction, Footwear, Electrical & Electronics, Medical, and Others), and Regional Forecast, 2020-2027.” The study further mentions that the thermoplastic elastomers (TPEs) market size was USD 26,856.8 million in 2019 and is projected to reach USD 39,424.6...

Continue reading

Ørsted to present results for first quarter 2021 on 29 April

Ørsted will release its results for the first quarter of 2021 on Thursday 29 April 2021. The results will be released at approx. 8:00 CEST. In connection with the presentation of the interim financial report, an earnings call for investors and analysts will be held on the same day at 14:00 CEST. Dial in numbers for the earnings call:Denmark: +45 7872 3251US: +1 833 526 8384UK: +44 333 300 9267 The earnings call can be followed live: https://edge.media-server.com/mmc/p/33swwkbd Presentation slides will be available prior to the earnings call:https://orsted.com/en/investors For further information, please contact: Media RelationsCarsten Birkeland Kjær+ 45 99 55 77 65cabkj@orsted.dk Investor RelationsAllan Bødskov Andersen+ 45 99 55 79 96ir@orsted.dk About ØrstedThe Ørsted vision is a world that runs entirely on green energy. Ørsted develops,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.